Pulished Date August, 2019
ID: 271
Share on
Share on

North America Hemophilia Management Market By Type (Hemophilia A, Hemophilia B) By Drug (Octocogalfa, Nonacogalfa, Desmopressin And Other Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2018-2023)

Pulished: August, 2019
ID: 271
Pages: 143

Overview of the Market:
The North America Hemophilia Management Market was worth $1.87 billion in 2018 and estimated to be growing at a CAGR of 1.52%, to reach $2.02 billion by 2023. Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting.

Hemophilia is categorized into three levels depending on its severity as severe, moderate and mild. About 80% of the hemophilia patients are considered to suffer from severe type. CDC estimates that in United States one in every 5000 newborn children is affected by Hemophilia A and one in every 30,000 is suffering from hemophilia B

North America hemophilia management market is driven by key factors such as growing prevalence of the disease; increasing usage of recombinant product, technological advancements. Rising investments in Research and developments for hemophilia products is also a major factor fuelling the growth of the market. However lack of available medication, stringent regulatory approvals and high cost of treatment are the key factors hindering the market growth.

North American market for Hemophilia management is segmented on the basis of type of hemophilia and drug. By type of hemophilia it is analysed as Hemophilia A and Hemophilia B. On the basis drug the market is segmented into Octocogalfa, Nonacogalfa, Desmopressin and other drugs. Hemophilia A is the largest segement and also estimated to be the fastest growing segment during the forecast period due to large number of patients suffering from hemophilia A

Geographical Analysis: 
Based on geography North America hemophilia management market is analyzed under two regions namely United States and Canada. North America is the largest market for hemophilia management accounting for approximately XX%. With North America, United States is the largest market for hemophilia management due to high government support and the increasing number of patients suffering from hemophilia. Canada is estimated to be the fastest growing region due to high growth potential due to increasing usage of available medication.

Key Players in this Market: 
Some of the major companies discussed in the report are Biogen, Baxter International Inc., Pfizer Inc., Bayer Pharma AG, Novo Nordisk A/S, Grifols International SA, CSL Behring, Octapharma and Swedish Orphan Biovitrum AB

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

  1. Market Segmentation

                5.1 BY Type                                        

                                5.1.1 Hemophilia A                         

                                5.1.2 Hemophilia B                         

                5.2 By Drug                                        

                                5.2.1 Octocogalfa                            

                                5.2.2 Nonacogalfa                           

                                5.2.3 Desmopressin                       

                                5.2.4 Other drugs                            

  1. Geographical Analysis

                                6.1 Introduction                              

                                6.2 United States                            

                                6.3 Canada                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

  1. Market Leaders' Analysis

                8.1 Biogen                                          

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Baxter International Inc.                                       

                8.4 Bayer Pharma AG                                    

                8.5 Novo Nordisk A/S                                    

                8.6 Grifols International SA                                         

                8.7 CSL Behring                                

                8.8 Octapharma                                               

                8.9 Swedish Orphan Biovitrum AB                                            

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 


a) List of Tables

b) List of Figures

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Hemophilia Management Market By Region, From 2018-2023 (USD Million)           
  2. North America Hemophilia Management Market By Type, From 2018-2023 (USD Million)         
  3. North America Hemophilia-A Market By Region, From 2018-2023 (USD Million)                                                  
  4. North America Hemophilia-B Market By Region, From 2018-2023 (USD Million)                                                  
  5. North America Hemophilia Management Market By Drug, From 2018-2023 (USD Million)
  6. North America Octocogalfa Market By Region, From 2018-2023 (USD Million)                                                      
  7. North America Nonacogalfa Market By Region, From 2018-2023 (USD Million)                                                     
  8. North America Desmopressin Market By Region, From 2018-2023 (USD Million)                                                 
  9. North America Other drugs Market By Region, From 2018-2023 (USD Million)                                                      
  10. United States Hemophilia Management Market By Type, From 2018-2023 (USD Million)                 
  11. United States Hemophilia Management Market By Drug, From 2018-2023 (USD Million) 
  12. Canada Hemophilia Management Market By Type, From 2018-2023 (USD Million)
  13. Canada Hemophilia Management Market By Drug, From 2018-2023 (USD Million)

Please wait. . . . Your request is being processed


$ 1234 3335

Click for Request Sample